Emcure Pharmaceuticals Ltd., a leading Indian pharmaceutical company, and its subsidiary, Gennova Biopharmaceuticals Limited, have signed a 22.78 MWp DC Solar Power Purchase Agreement (PPA) with Sunsure Energy, a major renewable power producer in India. This partnership will provide Emcure and Gennova with approximately 36 million kWh of clean energy annually for their Pune plants. According to Emcure, this deal will fulfill around 67% of their power needs with green energy and reduce CO2 emissions by 29,765.71 metric tons per year. As part of the PPA, Emcure and Gennova will acquire a stake in Sunsure Solarpark Twelve Private Limited, under a group captive scheme in accordance with the Electricity Act, 2023. Sunsure will supply the power from its 150 MWp DC solar plant in Solapur, Maharashtra.
Emcure signs 22.78 MWp solar power agreement
Emcure and Gennova will acquire a stake in Sunsure Solarpark Twelve Private Limited as part of the agreement. (Image Credit: Pixabay)
Scatec has secured EUR 25 million from IFU, alongside equity and non-recourse debt, for its USD 85 million project financing. (Image Source: Scatec ASA)
EliTe Solar launched its 5 GW PV project in Egypt’s TEDA Suez Zone, set to begin production by September 2025. (Image Source: PRNewswire)
Part of SECI’s 2 GW ISTS initiative, the project will deliver four hours of peak power daily for 25 years. (Image Credit/Source: Pixabay/Pexels)
Ethical Power Italia’s first EPC projects in Italy, two solar farms for Encavis AG, will generate 28 GWh annually. (Image Credit/Source: TomFisk/Pexels)